Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Animal Model Market In The Coming Years?

The market size of animal models has seen a robust growth in the recent past. The estimated growth is from $1.92 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This noticeable growth during the historic period is due to several factors such as increased usage of animal models for biomedical studies, escalated spending, and substantial investment in discovering and developing drugs. Additionally, the emphasis on precision medicine and the wide-ranging applications of animal models across the healthcare sector have also contributed to the market growth.

The market size for animal models is anticipated to witness robust growth in the coming years, expanding to “$2.8 billion in 2029 with a compound annual growth rate (CAGR) of 7.9%. The factors contributing to this growth in the predicted period are linked to the progress in genetic engineering, a heightened emphasis on personalized medicine, an increasing prevalence of chronic ailments, an escalating demand for successful vaccines and treatments, and a heightened investment in biomedical research. Major trends in the predicted period include a growing requirement for animal models in the stages of drug discovery and development, an increasing prevalence of chronic illnesses, physiological resemblances between humans and animals shorten drug development duration, growing consumption of personalized medicine fuelling the demand for humanized mice models, and remarkable market growth due to the rising implementation of animal models in biomedical research.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

What External And Internal Drivers Are Influencing The Animal Model Market?

The animal model market’s growth is anticipated to be fuelled by expanding pharmaceutical research and development investment activities. The process of pharmaceutical research and development, where scientific knowledge and innovative ideas combine to produce medical breakthroughs, is intricate. Exciting new treatments, the quest for solutions to complex diseases, and both scientific curiosity and business prospects within the healthcare sector are driving this research and development. Animal models play an essential role in predicting drug efficacy, safety, and toxicity during pharmaceutical research. They offer insight into biological processes, contribute to the creation of novel treatments, and replicate human physiological responses and disease progression in a controlled environment. For instance, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade group and lobbying organization, reported pharmaceutical research and development expenditure in Europe of €44,500 million ($47,999 million) in 2022 and €42,533 million ($45,877 million) in 2021, further emphasizing the significance of growing investment in pharmaceutical research and development in propelling the animal model market.

Which Segmentation Factors Are Critical In The Animal Model Market Analysis?

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

What Are The Dominant Trends Currently Seen In The Animal Model Market?

Leading firms in the animal model market are concentrating on the creation of innovative products like triple-immunodeficient animal models. These models enhance the precision and trustworthiness of preclinical studies, bolster advanced biomedical research, and expedite the development of new therapies for severe human illnesses. Triple-immunodeficient animal models, often mice, are meticulously engineered animals that are devoid of three vital components of the immune system. Their importance in biomedical research is unparalleled, particularly in the study of human diseases and the formulation of new treatments. For instance, Charles River Laboratories International, Inc., a pharmaceutical firm stationed in the United States, introduced NCG mouse strains (a type of triple-immunodeficient mouse model) for use in oncology research in January 2024. NCG mice lack functional/mature T, B, and NK cells and exhibit diminished function in macrophages and dendritic cells. These animal models can house xenograft cells, tissues, and human immune system components. They are perfect for studies in several fields including oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. Furthermore, NCG mice can be used to simulate the human immune system by engrafting PBMCs or CD34+ stem cells, thereby forming what are known as “humanized mice”.

Which Organizations Are At The Forefront Of The Animal Model Market?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Which Region Is Leading Innovation In The Animal Model Market?

North America was the largest region in the animal model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model